CBX2 and breast neoplasm: This result is consistent with a report that found that high levels of CBX2 protein expression in breast tumours was associated with an increased risk of mortality.23 However, no survival differences were detected between patients with tumours that do versus do not overexpress CBX2 within each the 5 molecular subtypes (q > 0.05).